86
Views
9
CrossRef citations to date
0
Altmetric
Review

Targeted therapies for diarrhea-predominant irritable bowel syndrome

Pages 69-100 | Published online: 25 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Brian E Lacy. (2016) Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. International Journal of General Medicine 9, pages 7-17.
Read now
Brooks D. Cash, Brian E. Lacy, Tharaknath Rao & David L. Earnest. (2016) Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?. Expert Opinion on Pharmacotherapy 17:3, pages 311-322.
Read now

Articles from other publishers (7)

Anu Kemppinen, Carol Howell, Victoria Allgar, Matthew Dodd, John Gregson, Charles Knowles, John McLaughlin, Preeti Pandya, Peter Whorwell, Elena Markaryan & Yan Yiannakou. (2020) Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Trials 21:1.
Crossref
Ling Yue, Min Chen, Tai-Chun Tang, Tian-Wei She, Yao-Yao Chen & Hui Zheng. (2018) Comparative effectiveness of pharmacological treatments for patients with diarrhea-predominant irritable bowel syndrome. Medicine 97:31, pages e11682.
Crossref
Darshan V. Chaudhary, Daxesh P. Patel, Jaivik V. Shah, Priyanka A. Shah, Mallika Sanyal & Pranav S. Shrivastav. (2015) Application of a UPLC-MS/MS method for the analysis of alosetron in human plasma to support a bioequivalence study in healthy males and females. Biomedical Chromatography 29:10, pages 1527-1534.
Crossref
H. L. DuPont. (2014) Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 39:10, pages 1033-1042.
Crossref
Raouf Hilal, Patricia Mitchell, Ernesto Guerra Jr.Bruce P. Burnett. (2014) Case Series of 10 Drug-Refractory IBS Patients Who Respond to Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI). Open Journal of Gastroenterology 04:10, pages 321-328.
Crossref
Marta Sobczak, Maciej Sałaga, Martin A. Storr & Jakub Fichna. (2013) Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. Journal of Gastroenterology 49:1, pages 24-45.
Crossref
Arnold Wald. (2012) Irritable bowel syndrome – Diarrhoea. Best Practice & Research Clinical Gastroenterology 26:5, pages 573-580.
Crossref